Global Pharmaceutical Packaging Market Size By Material (Glass, Metal, Plastic, and Paper & Paperboard), Product Type (Bottles, Blisters, Caps & Closures, Syringes, Vials & Ampoules, Bags & Pouches, Sachet and Others), Drug Delivery (Oral Drugs, Injectable, Topical, Ocular/ Ophthalmic, Nasal, Pulmonary, Transdermal and Others), By Packaging Type (Primary, Secondary and Tertiary) and Region - Market Share, Trend Analysis, Competitive Intelligence, Historical Data, and Forecast 2023 - 2030
Market Perspective
The global Pharmaceutical Packaging Market was worth USD 96.95 billion in 2022 and is anticipated to grow to USD 144.20 billion by 2030 at a CAGR of around 8.90% between 2023 and 2030.
Pharmaceutical packaging refers to the process of designing, manufacturing, and labeling packaging materials for pharmaceutical products to ensure their safety, integrity, and compliance with regulations at regional as well as global levels. The market is estimated to grow significantly over 2023-2030 due to the rising global population, along with the increasing prevalence of chronic diseases, and the development of healthcare infrastructure in emerging economies. These trends have led to higher consumption of pharmaceutical products. Additionally, stringent government regulations regarding packaging standards and the need for tamper-evident packaging have stimulated market growth.
Market trends are indicating a shift toward sustainable and eco-friendly packaging materials, the adoption of smart packaging technologies for better traceability, and the rise of personalized medicine packaging. This shift is further driven by increasing environmental awareness regarding conventional packaging materials and the implementation of new recycling regulations. These packaging methods are crucial for safeguarding drugs during transportation and storage, ensuring they are shielded from physical damage and environmental factors that could lead to contamination.
Furthermore, with a growing emphasis on patient-centric packaging and innovative solutions to enhance drug safety and compliance, the market is likely to offer significant opportunities for key manufacturers. Strategic collaborations or partnerships among IoMT and manufacturers are expected to contribute to the market value exponentially. North America, Europe, and Asia-Pacific are among the major regions experiencing significant growth. Furthermore, growth strategies such as product innovations and investments in R&D by key players present opportunities of growth.
Key Insights
- Based on material, the plastics segment held the dominating position in 2022
- Based on product type, the bottles segment acquired the largest market share in 2022
- Based on packaging type, the primary packaging segment is expected to grow at the highest CAGR over the forecast period
- On the basis of region, North America accounted for the largest market share in 2022
Rising Healthcare Expenditure Boosts Pharmaceutical Packaging Market Development
The increasing expenditure on healthcare worldwide is a key factor supporting the growth of the pharmaceutical packaging market. According to the World Health Organization (WHO), global healthcare spending is projected to reach USD 10.06 trillion by 2023, representing a significant increase compared to previous years. As healthcare budgets expand, pharmaceutical companies are investing heavily in research and development, leading to the introduction of new drugs and therapies. These developments, in turn, create a strong demand for secure and compliant packaging solutions to protect and deliver these pharmaceutical products safely to patients. Additionally, the continuous investment in R&D is resulting in the introduction of a wide range of innovative drugs and therapies. For instance, the pharmaceutical industry has witnessed a record number of new drug approvals in recent years, with the U.S. Food and Drug Administration (FDA) approving 59 novel drugs in 2021 alone.
Moreover, pharmaceutical companies are allocating a substantial portion of their budgets to research and development activities. The global pharmaceutical R&D expenditure exceeded USD 200 billion in 2022, with an increasing focus on developing advanced therapies and personalized medicine.
Regulatory Compliance Challenges Constrain Pharmaceutical Packaging Market Growth
The growth of the market is hindered by notable challenges arising from stringent regulatory requirements imposed by governments and international agencies. These guidelines are in place to guarantee the safety and effectiveness of pharmaceutical products. Complying with these regulations necessitates substantial resources and expertise, which can pose a challenge for smaller packaging companies. Additionally, the constant need to adapt to evolving regulations can result in escalated costs and delays in product launches, thereby impeding the overall growth of the market.
Governments and regulatory bodies globally, such as the U.S. FDA and the European Medicines Agency (EMA), enforce stringent guidelines to ensure the quality, safety, and efficacy of pharmaceutical products. These regulations encompass various aspects, including labeling requirements, packaging materials, child-resistant packaging, and tamper-evident features. Additionally, meeting regulatory requirements demands significant resources, including investments in technology, equipment, and personnel training. This can pose challenges for smaller packaging companies with limited budgets and capabilities, as they may struggle to keep up with the necessary infrastructure and expertise necessary for compliance. Constant updates to regulatory guidelines and standards can lead to increased costs for pharmaceutical packaging companies. Adapting packaging designs, materials, and manufacturing processes to adhere to evolving regulations requires time and investments. This, in turn, can result in delays in product launches and time-to-market, thereby impacting market growth and competitiveness.
Recent Development
April 2022 (Product Innovation) – Amcor, a renowned global company specializing in the development and manufacturing of environmentally responsible packaging solutions, unveiled an expansion to its pharmaceutical packaging range. This expansion includes the introduction of innovative High Shield laminates designed to offer enhanced sustainability. These new packaging options not only meet the demanding high barrier and performance standards set by the pharmaceutical industry but also align with the recycling goals of pharmaceutical companies. By prioritizing low carbon emissions and recyclability, Amcor aims to provide pharmaceutical companies with packaging solutions that are both eco-friendly and effective in preserving the integrity of their products.
Segmentation Analysis
Based on material, the market is further segmented into plastics, paper & paperboard, glass and metal. The plastics segment accounted for the largest market share due to high compatibility, ease of handling, and convenient designs. Plastics are widely utilized for their exceptional resistance to breakage and damage as compared to other materials. Additionally, plastics offer a wide range of properties and characteristics that make them highly versatile and suitable for various applications. Moreover, plastics exhibit excellent resistance to various chemicals, making them ideal for packaging materials. However, increasing concerns regarding pharmaceutical waste management and the availability of sustainable packaging solutions, paper and paperboard packaging materials are estimated to register significant revenue by 2030.
Based on product type, the market is further categorized into bottles, blisters, caps & closures, syringes, vials & ampoules, bags & pouches, sachet and others. The bottles segment dominated the market in 2022 due to its suitability for both solid and liquid forms as they can be customized to meet specific requirements, such as for nasal sprays and ophthalmic drops. For instance, nasal sprays and ophthalmic drops require specialized bottle designs to ensure proper dispensing and dosage accuracy. Bottles provide an effective means of protecting and preserving the contents. They can be made from materials that offer excellent barrier properties, ensuring that the product remains intact, free from contaminants, and maintains its quality over time.
Based on packaging type, the market is divided into primary, secondary and tertiary. The primary segment accounted for the largest market share in 2022 and is estimated to continue its dominance over 2023-2030. This segment holds significant importance as it directly interfaces with the drug, ensuring its protection and integrity. Moreover, the primary packaging serves as a vital source of information for healthcare professionals and patients. It contains essential details about the drug, including dosage instructions, precautions, expiration dates, and the manufacturer's information. This comprehensive labeling helps ensure the safe and effective use of the medication. Additionally, the primary packaging plays a crucial role in maintaining the stability and quality of the drug throughout its shelf life. It is designed to provide a barrier against external factors such as moisture, light, and contaminants, thereby safeguarding the drug's efficacy.
Regional Landscape
North America accounted for the largest revenue in 2022 and is anticipated to maintain its dominance between 2023 and 2030. The region's significant healthcare expenditure, coupled with advancements in technology, plays a crucial role in this dominance. Moreover, the increasing adoption of cutting-edge packaging solutions specifically tailored for the pharmaceutical industry is expected to stimulate market growth. The region's focus on technological advancements, such as automation, robotics, and digitalization, has significantly impacted pharmaceutical packaging industry outlook. These advancements have led to improved manufacturing processes, enhanced quality control, and increased efficiency, thereby bolstering market growth.
The introduction of nanotechnology in pharmaceutical packaging has revolutionized the industry. Nanotechnology offers various benefits, such as increased drug stability, controlled release, and improved bioavailability. The U.S. has been actively incorporating nanotechnology advancements into its manufacturing processes, thereby driving regional market growth.
Asia Pacific is anticipated to exhibit a remarkable CAGR over the forecast period. The rapid expansion of the pharmaceutical industry in the region coupled with manufacturing and research activities, particularly in countries such as India and China, is driving demand for pharmaceutical packaging solutions. Moreover, the region hosts a substantial segment of the global population, which is continually expanding. The rising population creates a higher demand for pharmaceutical products, which, in turn, fuels the need for efficient and reliable packaging solutions. With a growing focus on improving healthcare infrastructure and accessibility, along with the implementation of favorable regulatory policies, several countries in Asia Pacific have made significant strides. These policies aim to attract investments, promote research and development, and ensure the availability of quality healthcare services. This improved access to healthcare services encourages individuals to seek medical treatment and purchase pharmaceutical products, leading to an increased demand for packaging solutions.
Competitive Landscape
The global pharmaceutical packaging market is fragmented with key players such as SCHOTT AG, Amcor plc, AptarGroup, Inc., West Pharmaceutical Services, Inc., Berry Global Inc., Gerresheimer AG, WestRock Company, Becton, Dickinson U.K. Ltd, O-I Glass, Inc., and SGD Pharma. Companies employ a variety of strategic measures such as acquisitions, mergers, partnerships, product introductions, and collaborations to expand their business globally and enhance their competitive position.
The global Pharmaceutical Packaging Market is segmented as follows:
By Material
- Glass
- Metal
- Plastic
- Paper & Paperboard
By Product Type
- Bottles
- Blisters
- Caps & Closures
- Syringes
- Vials & Ampoules
- Bags & Pouches
- Sachet
- Others
By Drug Delivery
- Oral Drugs
- Injectable
- Topical
- Ocular/Ophthalmic
- Nasal
- Pulmonary
- Transdermal
- Others
By Packaging Type
- Primary
- Secondary
- Tertiary
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Rest of Asia-Pacific
- Middle East & Africa
- GCC
- South Africa
- North America
- Rest of Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
ARE YOU SEEKING COMPREHENSIVE INSIGHT ON VARIOUS
MARKETS?
CONTACT OUR EXPERTS TODAY
Speak to an Expert
Global Pharmaceutical Packaging Market Size By
- March-2024
- 160
- Global
- healthcare-medical-devices-biotechnology
Related Research
2022-2030 Global and Regional B-Cell Non-Hodgkin`s Lymphoma (NHL) Treatment Industry Production, Sa
February-2021
2022-2030 Global and Regional Organ Transplant Diagnostics Industry Production, Sales and Consumpti
February-2021
2022-2030 Global and Regional Prostacyclin Drug Industry Production, Sales and Consumption Status a
February-2021
2022-2030 Global and Regional Spinal and Bulbar Muscular Atrophy Treatment Industry Production, Sal
February-2021
2% Chlorhexidine Gluconate (CHG) Cloths-Global Market Status & Trend Report 2022-2030 Top 20 Countri
April-2021
2021-2027 Global and RegioAnal Nasal Gels Industry Production, Sales and Consumption Status and Pros
February-2021
2021-2027 Global and Regional 2019-nCoV Detection Server Industry Production, Sales and Consumption
February-2021
2021-2027 Global and Regional ? Collagen Quantitative Determination Kit Industry Production, Sales a
February-2021
2021-2027 Global and Regional Anti-TNF Monoclonal Antibody Industry Production, Sales and Consumptio
February-2021